<VariationArchive VariationID="556886" VariationName="NM_000286.3(PEX12):c.644del (p.Pro215fs)" VariationType="Deletion" Accession="VCV000556886" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-04-06" DateCreated="2018-08-05" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="548058" VariationID="556886">
      <GeneList>
        <Gene Symbol="PEX12" FullName="peroxisomal biogenesis factor 12" GeneID="5193" HGNC_ID="HGNC:8854" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="35574795" stop="35578571" display_start="35574795" display_stop="35578571" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="33901813" stop="33905655" display_start="33901813" display_stop="33905655" Strand="-" />
          </Location>
          <OMIM>601758</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000286.3(PEX12):c.644del (p.Pro215fs)</Name>
      <CanonicalSPDI>NC_000017.11:35577073:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="35577074" stop="35577074" display_start="35577074" display_stop="35577074" variantLength="1" positionVCF="35577073" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="33904093" stop="33904093" display_start="33904093" display_stop="33904093" variantLength="1" positionVCF="33904092" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>P215fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.33904094del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.33904094del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.35577075del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.35577075del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008447.1" sequenceAccession="NG_008447" sequenceVersion="1" change="g.6564del">
            <Expression>NG_008447.1:g.6564del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000286.3" sequenceAccession="NM_000286" sequenceVersion="3" change="c.644del" MANESelect="true">
            <Expression>NM_000286.3:c.644del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000277.1" sequenceAccession="NP_000277" sequenceVersion="1" change="p.Pro215fs">
            <Expression>NP_000277.1:p.Pro215fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1199283977" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000286.3(PEX12):c.644del (p.Pro215fs) AND multiple conditions" Accession="RCV000672949" Version="1">
        <ClassifiedConditionList TraitSetID="10246">
          <ClassifiedCondition DB="MedGen" ID="C3553929">Peroxisome biogenesis disorder 3A (Zellweger)</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3550693">Peroxisome biogenesis disorder type 3B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-02-26" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000286.3(PEX12):c.644del (p.Pro215fs) AND Peroxisome biogenesis disorder 3A (Zellweger)" Accession="RCV003653257" Version="1">
        <ClassifiedConditionList TraitSetID="8948">
          <ClassifiedCondition DB="MedGen" ID="C3553929">Peroxisome biogenesis disorder 3A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-08-05" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15542397</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21031596</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-17">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="10246" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4320" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder type 3B</ElementValue>
                <XRef ID="MONDO:0009959" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD3B</ElementValue>
                <XRef Type="MIM" ID="266510" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15226" />
                <XRef ID="15226" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <XRef ID="44" DB="Orphanet" />
              <XRef ID="772" DB="Orphanet" />
              <XRef ID="C3550693" DB="MedGen" />
              <XRef ID="MONDO:0009959" DB="MONDO" />
              <XRef Type="MIM" ID="266510" DB="OMIM" />
            </Trait>
            <Trait ID="17429" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 3A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013927" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)</ElementValue>
                <XRef Type="Allelic variant" ID="601758.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 3A</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD3A</ElementValue>
                <XRef ID="GTR000522760" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614859" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15858" />
                <XRef ID="15858" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The peroxisomal biogenesis disorder (PBD) Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 3 (CG3) have mutations in the PEX12 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614859" DB="OMIM" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3553929" DB="MedGen" />
              <XRef ID="MONDO:0013927" DB="MONDO" />
              <XRef Type="MIM" ID="614859" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8948" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17429" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 3A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013927" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)</ElementValue>
                <XRef Type="Allelic variant" ID="601758.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 3A</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD3A</ElementValue>
                <XRef ID="GTR000522760" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614859" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15858" />
                <XRef ID="15858" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The peroxisomal biogenesis disorder (PBD) Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 3 (CG3) have mutations in the PEX12 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614859" DB="OMIM" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3553929" DB="MedGen" />
              <XRef ID="MONDO:0013927" DB="MONDO" />
              <XRef Type="MIM" ID="614859" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1548411" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="2193462|OMIM:266510;614859" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000798108" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-02-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="T" referenceAllele="TG" start="33904092" stop="33904093" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000286.2:c.644delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="266510" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614859" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8164488" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="15919942|MedGen:C3553929" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004374558" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15542397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 556886). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PEX12 protein in which other variant(s) (p.Gln349del) have been determined to be pathogenic (PMID: 15542397, 21031596; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with PEX12-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.1%). This sequence change creates a premature translational stop signal (p.Pro215Glnfs*6) in the PEX12 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 145 amino acid(s) of the PEX12 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.33904093del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553929" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8164488" TraitType="Disease" MappingType="XRef" MappingValue="C3553929" MappingRef="MedGen">
        <MedGen CUI="C3553929" Name="Peroxisome biogenesis disorder 3A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1548411" TraitType="Disease" MappingType="XRef" MappingValue="614859" MappingRef="OMIM">
        <MedGen CUI="C3553929" Name="Peroxisome biogenesis disorder 3A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1548411" TraitType="Disease" MappingType="XRef" MappingValue="266510" MappingRef="OMIM">
        <MedGen CUI="C3550693" Name="Peroxisome biogenesis disorder type 3B" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

